The African Programme for Onchocerciasis Control: impact on onchocercal skin disease

Objectives  To assess the long‐term impact of the African Programme for Onchocerciasis Control on itching and onchocercal skin disease (OSD).

[1]  J. Okeibunor,et al.  Where would I be without ivermectin? Capturing the benefits of community‐directed treatment with ivermectin in Africa , 2011, Tropical medicine & international health : TM & IH.

[2]  Daniel Pilger,et al.  Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. , 2010, Bulletin of the World Health Organization.

[3]  African Programme for Onchocerciasis Control - report of the sixth meeting of National Task Forces, October 2009. , 2010, Releve epidemiologique hebdomadaire.

[4]  L. Konaté,et al.  Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.

[5]  U. Amazigo The African Programme for Onchocerciasis Control (APOC) , 2008, Annals of tropical medicine and parasitology.

[6]  A. Onapa,et al.  After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues , 2008, Tropical medicine & international health : TM & IH.

[7]  I. Dozie,et al.  The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south–eastern Nigeria , 2007, Annals of tropical medicine and parasitology.

[8]  F. Richards,et al.  A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. , 2004, The American journal of tropical medicine and hygiene.

[9]  A. Hopkins,et al.  The effect of 5 years of annual treatment with ivermectin (Mectizan®) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic , 2002, Annals of tropical medicine and parasitology.

[10]  M. Murdoch,et al.  Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa , 2002, Annals of tropical medicine and parasitology.

[11]  P. Enyong,et al.  Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC) , 2002, Annals of tropical medicine and parasitology.

[12]  M. Strong,et al.  Interventions for treating scabies. , 2007, The Cochrane database of systematic reviews.

[13]  Ogbuagu,et al.  The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial , 1998, Tropical medicine & international health : TM & IH.

[14]  B. Benton Economic impact of onchocerciasis through the African Programme Onchocerciasis Control: control for an overview , 1998 .

[15]  B. Benton Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview. , 1998, Annals of tropical medicine and parasitology.

[16]  E S Alley,et al.  The impact of Mectizan on the transmission of onchocerciasis. , 1998, Annals of tropical medicine and parasitology.

[17]  O. Oladepo,et al.  Farm land size and onchocerciasis status of peasant farmers in south‐western Nigeria , 1997, Tropical medicine & international health : TM & IH.

[18]  M. Downham,et al.  Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis , 1996, Tropical medicine & international health : TM & IH.

[19]  J. Whitworth,et al.  Maintaining compliance to ivermectin in communities in two West African countries. , 1996, Health policy and planning.

[20]  G. Burnham Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. , 1995, The American journal of tropical medicine and hygiene.

[21]  P. Ngoumou,et al.  A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. , 1994, Annals of tropical medicine and parasitology.

[22]  S. Cousens,et al.  Ivermectin and onchocercal optic neuritis: Short-term effects , 1994, Eye.

[23]  J. Evans,et al.  Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis , 1993, The Lancet.

[24]  P. Enyong,et al.  A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments. , 1993, American Journal of Tropical Medicine and Hygiene.

[25]  S. Diallo,et al.  EFFICACY AND TOLERANCE OF IVERMECTININ HUMAN ONCHOCERCIASIS , 1982, The Lancet.

[26]  S. Diallo,et al.  Efficacy and tolerance of ivermectin in human onchocerciasis. , 1982, Lancet.

[27]  S. G. Browne Onchocercal depigmentation. , 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene.